Implication of Wt1 in the pathogenesis of nephrogenic failure in a mouse model of retinoic acid-induced caudal regression syndrome

American Journal of Pathology

Volumn 166, Issue 5, 2005, Pages 1295-1307

  Tse, Herman K W ^a   Leung, Maran B W ^a   Woolf, Adrian S ^b   Menke, Aswin L ^c,d   Hastie, Nicholas D ^c   Gosling, John A ^a,e   Pang, Chi Pui ^a   Shum, Alisa S W ^a,f  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; WT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAUDAL REGRESSION SYNDROME; CONTROLLED STUDY; DRUG INDUCED DISEASE; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GENETIC RECOMBINATION; KIDNEY AGENESIS; KIDNEY DEVELOPMENT; KIDNEY MALFORMATION; MESENCHYME; MOUSE; NEPHROBLASTOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 17844387376     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62349-8     Document Type: Article

References (72)

1. Woolf AS, Welham SJM, Hermann MM, Winyard PJD: Maldevelopment of the human kidney and lower urinary tract: an overview. The Kidney: From Normal Development to Congenital Disease. Edited by Vize PD, Woolf AS, Bard JBL. Amsterdam, Elsevier Science/Academic Press, 2003, pp 377-393
2. Belk RA, Thomas DFM, Mueller RF, Godbole P, Markham AF, Weston MJ: A familial study and the natural history of prenatally detected unilateral multicystic dysplastic kidney. J Urol 2002, 167:666-669
3. Hiraoka M, Tsukahara H, Ohshima Y, Kasuga K, Ishihara Y, Mayumi M: Renal aplasia is the predominant cause of congenital solitary kidneys. Kidney Int 2002, 61:1840-1844
4. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon AR, Woolf AS: Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 1996, 49:135-146
5. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT1 is required for early kidney development. Cell 1993, 74:679-691
6. Porteous S, Torban E, Cho NP, Cunliffe H, Chua L, McNoe L, Ward T, Souza C, Gus P, Giugliani R, Sato T, Yun K, Favor J, Sicotte M, Goodyer P, Eccles M: Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu)+/- mutant mice. Hum Mol Genet 2000, 9:1-11
7. Woolf AS, Thiruchelvam N: Congenital obstructive uropathy-its origin and contribution to end-stage renal failure in children. Adv Ren Replace Ther 2001, 8:157-163
8. Nyirady P, Thiruchelvam N, Fry CH, Godley ML, Winyard PJD, Peebles DM, Woolf AS, Cuckow PM: Effects of in utero bladder outflow obstruction on fetal sheep detrusor contractility, compliance and innervation. J Urol 2002, 168:1615-1620
9. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T: In utero and in vitro exposure to β-lactams impairs kidney development in the rat. J Am Soc Nephrol 2000, 11:874-884
10. Welham SJM, Wade A, Woolf AS: Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int 2002, 61:1231-1242
11. Rubenstein MA, Bucy JG: Caudal regression syndrome: the urologic implications. J Urol 1975, 114:934-937
12. Andrish J, Kalamchi A, MacEwen GD: Sacral agenesis: a clinical evaluation of its management, heredity, and associated anomalies. Clin Orthop Relat Res 1979, 139:52-57
13. Sparnon AL, Ahmed S: Urotogical anomalies in the caudal regression syndrome. Aust N Z J Surg 1984, 54:365-367
14. Carson JA, Barnes PD, Tunell WP, Smith EI, Jolley SG: Imperforate anus: the neurological implication of sacral abnormalities. J Pediatr Surg 1984, 19:838-842
15. Bohring A, Lewin SO, Reynolds JF, Voigtländer T, Rittinger O, Carey JC, Köpernik M, Smith R, Zackai EH, Leonard NJ, Gritter HL, Bamforth JS, Okun N, McLeod DR, Super M, Powell P, Mundlos S, Hennekam RCM, van Langen IM, Viskochil DH, Wiedemann H-R, Opitz JM: Polytopic anomalies with agenesis of the lower vertebral column. Am J Med Genet 1999, 87:99-114
16. Pang D: Sacral agenesis and caudal spinal cord malformations. Neurosurgery 1993, 32:755-779
17. Wilson JG, Warkany J: Malformations in the genito-urinary tract induced by maternal vitamin A deficiency in the rat. Am J Anal 1948, 83:357-407
18. Wilson JG, Roth CB, Warkany J: An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration ot vitamin A at various times during gestation. Am J Anat 1953, 92:189-217
19. Mendelsohn C, Lohnes D, Décimo D, Lufkin T, LeMeur M, Chambon P, Mark M: Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994, 120:2749-2771
20. Kastner P, Mark M, Ghyselinck N, Krezel W, Dupé V, Grondona JM, Chambon P: Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 1997, 124:313-326
21. Batourina E, Choi C, Paragas N, Bello N, Hensle T, Costantini FD, Schuchardt A, Bacallao RJ, Mendelsohn CI: Distal ureter morphogenesis depends on epithelial cell remodelling mediated by vitamin A and Ret. Nat Genet 2002, 32:109-115
22. Batourina E, Gim S, Bello N, Shy M, Clagett-Dame M, Srinivas S, Costantini F, Mendelsohn C: Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat Genet 2001, 27:74-78
23. Vilar J, Gilbert T, Moreau E, Merlet-Bénichou A: Metanephros organogenesis is highly stimulated by vitamin A derivatives in organ culture. Kidney Int 1996, 49:1478-1487
24. Moreau E, Vilar J, Lelièvre-Pégorier M, Merlet-Bénichou C, Gilbert T: Regulation of c-ret expression by retinoic acid in rat metanephros: implications in nephron mass control. Am J Physiol 1998, 275:F938-F945
25. Lelièvre-Pégorier M, Vilar J, Ferrier M-L, Moreau E, Freund N, Gilbert T, Merlet-Bénichou C: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 1998, 54:1455-1462
26. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 2003, 348:101-108
27. Warkany J, Roth C: Congenital malformations induced in rats by maternal vitamin A deficiency. II. Effect of varying the preparatory diet upon the yield of abnormal young. J Nutrition 1948, 35:1-12
28. Dickman EC, Thaller C, Smith SM: Temporally-regulated retinoic acid depletion produces specific neural crest, ocular and nervous system defects. Development 1997, 124:3111-3121
29. White JC, Highland M, Clagett-Dame M: Abnormal development of the sinuatrial venous valve and posterior hindbrain may contribute to late fetal resorption of vitamin A-deficient rat embryos. Teratology 2000, 62:374-384
30. Robens JF: Teratogenic effects of hypervitaminosis A in the hamster and the guinea pig. Toxicol Appl Pharmacol 1970, 16:88-99
31. Shenefelt RE: Morphogenesis of malformations in hamsters caused by retinoic acid: relation to dose and stage at treatment. Teratology 1972, 5:103-118
32. Bernhardt IB, Dorsey DJ: Hypervitaminosis A and congenital renal anomalies in a human infant. Obstet Gynecol 1974, 43:750-755
33. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A: Teratogenicity of high vitamin A intake. N Engl J Med 1995, 333:1369-1373
34. Elmazar MMA, Reicherl U, Shroot B, Nau H: Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RARα, RARβ, and RARγ. Teratology 1996, 53:158-167
35. Shum ASW, Poon LLM, Tang WWT, Koide T, Chan BWH, Leung YC, Shiroishi T, Copp AJ: Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo. Mech Dev 1999, 84:17-30
36. Menke AL, Ijpenberg A, Fleming S, Ross A, Medine CN, Patek CE, Spraggon L, Hughes J, Clarke AR, Hastie ND: The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis. J Pathol 2003, 200:667-674
37. Delescluse C, Cavey MT, Martin B, Bernard BA, Reichert U, Maignan J, Darmon M, Shroot B: Selective high affinity retinoic acid receptor α or β-γ ligands. Mol Pharmacol 1991, 40:556-562
38. Gavrieli Y, Sherman Y, Ben-Sasson SA: TdT mediated dUTP-biotin nick end labeling of tissue sections (TUNEL). J Cell Biol 1992, 119:493-501
39. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie HD, Bard JBL: The expression of the Wilms' tumor gene, WT1, in the developing mammalian embryo. Mech Dev 1992, 40:85-97
40. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 1990, 109:787-795
41. Matsushita N, Fujita Y, Tanaka M, Nagatsu T, Kiuchi K: Cloning and structural organization of the gene encoding the mouse glial cell-line-derived neurotrophic factor, GDNF. Gene 1997, 203:149-157
42. Pachnis V, Mankoo B, Costantini F: Expression of the c-ret protooncogene during mouse embryogenesis. Development 1993, 119:1005-1017
43. Wilkinson DG: Whole mount in situ hybridisation of vertebrate embryos. In Situ Hybridisation. Edited by Wilkinson DG. Oxford, IRL Press, 1992, pp 75-83
44. Avner ED, Ellis D, Temple T, Jaffe R: Metanephric development in serum-free organ culture. In Vitro 1982, 18:675-682
45. Arafa HMM, Elmazar MMA, Hamada FMA, Reichert U, Shroot B, Nau H: Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch Toxicol 2000, 73:547-556
46. Elmazar MMA, Rühl R, Reichert U, Shroot B, Nau H: RARα-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways. Toxicol Appl Pharmacol 1997, 146:21-28
47. Grobstein C: Inductive interaction in the development of the mouse metanephros. J Exp Zool 1955, 130:319-340
48. Carroll TJ, McMahon AP: Overview: the molecular basis of kidney development. The Kidney: From Normal Development to Congenital Disease. Edited by Vize PD, Woolf AS, Bard JBL. Amsterdam, Elsevier Science/Academic Press, 2003, pp 343-376
49. Discenza MT, He S, Lee TH, Chu LL, Bolon B, Goodyer P, Eccles M, Pelletier J: WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene 2003, 22:8145-8155
50. Salnio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumäe U, Meng X, Lindahl M, Pachnis V, Sariola H: Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997, 124:4077-4037
51. Osumi-Yamashita N, Iseki S, Noji S, Nohno T, Koyama E, Taniguchi S, Doi H, Eto K: Retinoic acid treatment induces the ectopic expression of retinoic acid receptor β gene and excessive cell death in the embryonic mouse face. Dev Growth Differ 1992, 34:199-209
52. Griffith CM, Wiley MJ, Sanders EJ: The vertebrate tail bud: three germ layers from one tissue. Anat Embryol 1992, 185:101-113
53. Woolf AS, Palmer SJ, Snow ML, Fine LG: Creation of a functioning chimeric mammalian kidney. Kidney Int 1990, 38:991-997
54. Tam PPL: The histogenetic capacity of tissues in the caudal end of the embryonic axis of the mouse. J Embryol Exp Morph 1984, 82:253-266
55. Griffith CM, Wiley MJ: Direct effects of retinoic acid on the development of the tail bud in chick embryos. Teratology 1989, 39:261-275
56. Granata C, Wang Y, Puri P, Tanaka K, O'Briain DS: Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis. Br J Urol 1997, 80:140-144
57. McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, Smart N, Rutland P, Prescott N, Hopkins J, Bentley E, Shaw A, Roberts E, Mueller R, Jadeja S, Philip N, Nelson J, Francannet C, Perez-Aytes A, Megarbane A, Kerr B, Wainwright B, Woolf AS, Winter RM, Scambler PJ: Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 2003, 34:203-208
58. Attar R, Quinn F, Winyard PJD, Mouriquand PDE, Foxall P, Hanson MA, Woolf AS: Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys. Am J Pathol 1998, 152:1225-1235
59. Kessel M: Respecification of vertebral identities by retinoic acid. Development 1992, 115:487-501
60. Davies AP, Witte DP, Hsieh-Li HM, Potter SS, Capecchi MR: Absence of radius and ulna in mice lacking hoax-11 and hoxd-11. Nature 1995, 375:791-795
61. Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, MacMahon AP: Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev 1994, 8:174-189
62. Davies JA, Ladomery M, Hohenstein P, Michael L, Shafe A, Spraggon L, Hastie N: Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumor suppressor is required for nephron differentiation. Hum Mol Genet 2004, 13:235-246
63. Satre MA, Kochhar DM: Elevations in the endogenous levels of the putative morphogen retinoic acid in embryonic mouse limb-buds associated with limb dysmorphogenesis. Dev Biol 1989, 133:529-536
64. Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA: The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 1999, 98:663-673
65. Little M, Holmes G, Walsh P: WT1: what has the last decade told us? BioEssays 1999, 21:191-202
66. Scharnhorst V, van der Eb AJ, Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene 2001, 273:141-161
67. Wang Z-Y, Qiu Q-Q, Deuel TF: The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem 1993, 268:9172-9175
68. Srinivas S, Wu Z, Chen C-M, D'Agati V, Costantini F: Dominant effects of RET receptor misexpression and ligand-independent RET signalling on ureteric bud development. Development 1999, 126:1375-1386
69. Brophy PD, Ostrom L, Lang KM, Dressler GR: Regulation of ureteric bud outgrowth by Pax-2 dependent activation of the glial derived neurotrophic factor gene. Development 2001, 128:4747-4756
70. Donovan MJ, Natoli TA, Sainio K, Amstutz A, Jaenisch R, Sariola H, Kreidberg JA: Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud. Dev Genet 1999, 24:252-262
71. Dollé P, Ruberte E, Leroy P, Morriss-Kay G, Chambon P: Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 1990, 110:1133-1151
72. Niederreither K, McCaffery P, Dräger UC, Chambon P, Dollé P: Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech Dev 1997, 62:67-78